Summary results for ivermectin for COVID-19 from the large TOGETHER trial were just released No benefit whatsoever for ivermectin on risk of hospitalization or mortality in a mild outpatient grouppic.twitter.com/5eZj0pc5V6
You can add location information to your Tweets, such as your city or precise location, from the web and via third-party applications. You always have the option to delete your Tweet location history. Learn more
Sorry I mean low-risk. In comparison to other trials I'd say this was low-risk, but yes moderate is probably more reasonable
Definitely mild disease, but the investigators were wise to select a moderate RISK population for deterioration, so that they could demonstrate a benefit. If one enrolls healthy 20-30yo's in a trial, it's hard to decrease hospitalization if <5% event rate.
Yes that's fair. I'm confusing my terminology somewhat
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.